Compare TRX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRX | BVS |
|---|---|---|
| Founded | 1990 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.4M | 617.1M |
| IPO Year | 2002 | 2016 |
| Metric | TRX | BVS |
|---|---|---|
| Price | $1.40 | $10.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $1.70 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 3.9M | 440.5K |
| Earning Date | 04-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $84.84 | $7.52 |
| Revenue Next Year | $96.90 | $7.06 |
| P/E Ratio | ★ N/A | $32.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.30 | $5.81 |
| 52 Week High | $2.80 | $10.58 |
| Indicator | TRX | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 42.66 | 69.21 |
| Support Level | $1.23 | $8.43 |
| Resistance Level | $1.95 | N/A |
| Average True Range (ATR) | 0.11 | 0.38 |
| MACD | 0.00 | 0.13 |
| Stochastic Oscillator | 36.96 | 83.96 |
TRX Gold Corp is engaged in the exploration, development, and production of mineral property interests in the United Republic of Tanzania, focused on development and mining operations, and on exploring and evaluating its mineral properties. The business of exploring and mining for minerals involves a high degree of risk, and the underlying value of the mineral properties depends on the existence and economic recovery of mineral resources and reserves, as well as the ability to raise long-term financing to continue development. The company is focused on the Buckreef Gold Project, which comprises five prospects: Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba, and includes three main mineralized zones: Buckreef South, Buckreef Main, and Buckreef North.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.